Analysts Forecast Positive Outlook for Invesco S&P 500 Equal Weight ETF
The Invesco S&P 500 Equal Weight ETF (Symbol: RSP) shows promise as analysts project a significant upside based on corporate target prices.
After reviewing the underlying assets of RSP, we found that its implied analyst target price sits at $201.09 per unit. This is calculated by comparing the current trading price of the ETF to the anticipated average target prices set by analysts for its holdings. Currently, RSP trades at about $183.47 per unit, indicating an expected upside of 9.60% based on these forecasts.
Among RSP’s noteworthy holdings, three stocks stand out with strong upside potential: Moderna Inc (Symbol: MRNA), APA Corp (Symbol: APA), and Schlumberger Ltd (Symbol: SLB). Moderna recently traded at $42.86 per share, yet analysts project a target price of $80.52, marking an upside of 87.87%. Similarly, APA, currently priced at $22.38, has an average target of $31.68, suggesting a potential increase of 41.55%. Lastly, Schlumberger is trading at $41.56, with an analyst target of $58.75 per share, presenting an upside of 41.36%. Below is a chart illustrating the twelve-month performance of these companies:
A summary of current analyst target prices for these companies is provided in the table below:
Name | Symbol | Recent Price | Avg. Analyst 12-Mo. Target | % Upside to Target |
---|---|---|---|---|
Invesco S&P 500 Equal Weight ETF | RSP | $183.47 | $201.09 | 9.60% |
Moderna Inc | MRNA | $42.86 | $80.52 | 87.87% |
APA Corp | APA | $22.38 | $31.68 | 41.55% |
Schlumberger Ltd | SLB | $41.56 | $58.75 | 41.36% |
Investors may question whether analysts’ projections are realistic or overly ambitious. A high target price can indicate confidence, but it also risks being revised down if not aligned with market conditions. Investors should consider these factors carefully and conduct further research before making decisions.
10 ETFs With Most Upside To Analyst Targets »
Also see:
• Mergers and Acquisitions
• LLAP market cap history
• Roper Technologies RSI
The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.